The CLCN5 Knockout Raji Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout cell population derived from the Raji human B lymphoblastoid cell line. This product features targeted disruption of the CLCN5 gene, which encodes the voltage-gated chloride channel ClC-5, via CRISPR/Cas9-mediated gene editing. The resulting polyclonal pool provides a heterogenous loss-of-function model without clonal selection, enabling robust functional studies of ClC-5 in a B lymphocyte context.
The Raji cell line originates from a human Burkitt lymphoma and maintains an Epstein-Barr virus (EBV)-positive B lymphoblastoid phenotype. Widely utilized as a model for B lymphocyte biology and lymphomagenesis, Raji cells offer unlimited in vitro proliferation and suspension growth, facilitating large-scale experimental designs. Integrating the CLCN5 knockout into this background creates a specialized system to dissect endosomal chloride transport defects within B cells, particularly in processes such as antigen uptake and endocytic trafficking.
CLCN5 encodes ClC-5, a voltage-gated chloride channel localized to early endosomes. ClC-5 works in concert with the vacuolar H+-ATPase (V-ATPase) to promote endosomal acidification by providing a chloride shunt that neutralizes electrogenic proton pumping. This cooperative mechanism is critical for receptor-mediated endocytosis and lysosomal degradation. ClC-5 interacts with endosomal adaptor proteins and functions within a molecular network that includes Rab5 and early endosome antigen 1 (EEA1). Disruption of CLCN5 impairs chloride ion flux, leading to defective endosomal acidification, which attenuates endocytic trafficking and protein turnover. The channel is regulated by transcription factors that control endosomal function and responds to luminal pH, positioning it as a central node in endosomal homeostasis.
In Raji B cells, CLCN5 knockout underscores the dependency of lymphocyte functions on intact endosomal acidification. B lymphocytes rely on dynamic endosomal trafficking for antigen processing and MHC class II presentation. ClC-5 deficiency may perturb these pathways, providing a model to explore chloride-dependent regulation of B cell activation. Furthermore, CLCN5 mutations cause Dent disease, an X-linked renal disorder marked by proteinuria, nephrolithiasis, and renal failure. While not renal-derived, this Raji knockout population enables investigation of CLCN5 loss-of-function in a proliferative cellular environment, aiding dissection of molecular mechanisms underlying endolysosomal pathology.
This CLCN5 knockout model supports diverse assays to evaluate endosomal chloride transport and trafficking. Western blotting and RT-qPCR quantify ClC-5 ablation, while immunofluorescence visualizes endosomal marker redistribution. Functional analyses employ chloride- and pH-sensitive probes to measure endosomal acidification and chloride flux, directly assessing endocytic capacity. Applications include studying receptor-mediated internalization, lysosomal degradation, and signaling in B lymphocytes, as well as screening for compounds that rescue endosomal function in ClC-5-deficient states. For further information, please contact Ascent Research.
